• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性限制型心肌病的形态学谱

Morphologic spectrum of primary restrictive cardiomyopathy.

作者信息

Angelini A, Calzolari V, Thiene G, Boffa G M, Valente M, Daliento L, Basso C, Calabrese F, Razzolini R, Livi U, Chioin R

机构信息

Department of Pathology, University of Padua Medical School, Italy.

出版信息

Am J Cardiol. 1997 Oct 15;80(8):1046-50. doi: 10.1016/s0002-9149(97)00601-2.

DOI:10.1016/s0002-9149(97)00601-2
PMID:9352976
Abstract

A restrictive hemodynamic profile with left ventricular (LV) end-diastolic volume < 100 ml/m2 and LV end-diastolic pressure > 18 mm Hg, in the absence of endomyocardial, pericardial, and specific cardiomyopathy, is a peculiar feature of primary restrictive cardiomyopathy. From 1985 to 1994, 7 hearts of patients who met the above hemodynamic criteria and underwent endomyocardial biopsy because of heart failure, were studied through gross (5 cardiectomies and 2 autopsies), histologic, and electron microscopic investigations. Ages ranged from 9 to 48 years (mean age 29 +/- 13). Four patients (57%) had a positive family history: 2 for hypertrophic and 2 for restrictive cardiomyopathy. Three patterns were identified in the 7 hearts: (1) pure restrictive form in 4 cases with mass/volume ratio 1.2 +/- 0.5 g/ml, ejection fraction 58 +/- 5%, LV end-diastolic volume 67.5 +/- 12.6 ml/m2, LV end-diastolic pressure 26.7 +/- 3.5 mm Hg; (2) hypertrophic-restrictive form in 2 cases with mass/volume ratio 1.5 +/- 0.07 g/ml, ejection fraction 62 +/- 1%, LV end-diastolic volume 69 +/- 10 ml/m2, LV end-diastolic pressure 30 +/- 7 mm Hg; and (3) mildly dilated restrictive form in 1 case with mass/volume ratio 0.9 g/ml, ejection fraction 25%, LV end-diastolic volume 98 ml/m2, LV end-diastolic pressure 40 mm Hg. Histology and electron microscopy disclosed myocardial and myofibrillar disarray and endoperimysial interstitial fibrosis in each pattern. The familial forms suggest the presence of a genetic abnormality. Primary restrictive cardiomyopathy may present with or without hypertrophy and shares similar microscopic pictures with hypertrophic cardiomyopathy. The 2 entities may represent a different phenotypic expression of the same genetic disease.

摘要

在没有心内膜、心包和特定心肌病的情况下,左心室舒张末期容积<100 ml/m²且左心室舒张末期压力>18 mmHg的限制性血流动力学特征是原发性限制性心肌病的一个特殊特征。1985年至1994年,对7例符合上述血流动力学标准并因心力衰竭接受心内膜心肌活检的患者的心脏进行了大体(5例心脏切除术和2例尸检)、组织学和电子显微镜检查。年龄范围为9至48岁(平均年龄29±13岁)。4例患者(57%)有家族史:2例为肥厚型心肌病,2例为限制性心肌病。在7颗心脏中发现了三种模式:(1)4例为单纯限制性形式,质量/容积比为1.2±0.5 g/ml,射血分数为58±5%,左心室舒张末期容积为67.5±12.6 ml/m²,左心室舒张末期压力为26.7±3.5 mmHg;(2)2例为肥厚性限制性形式,质量/容积比为1.5±0.07 g/ml,射血分数为62±1%,左心室舒张末期容积为69±10 ml/m²,左心室舒张末期压力为30±7 mmHg;(3)1例为轻度扩张性限制性形式,质量/容积比为0.9 g/ml,射血分数为25%,左心室舒张末期容积为98 ml/m²,左心室舒张末期压力为40 mmHg。组织学和电子显微镜检查显示每种模式均有心肌和肌原纤维排列紊乱以及内膜周间质纤维化。家族性形式提示存在遗传异常。原发性限制性心肌病可能有或没有肥厚表现,并且与肥厚型心肌病有相似的微观图像。这两种实体可能代表同一遗传疾病的不同表型表达。

相似文献

1
Morphologic spectrum of primary restrictive cardiomyopathy.原发性限制型心肌病的形态学谱
Am J Cardiol. 1997 Oct 15;80(8):1046-50. doi: 10.1016/s0002-9149(97)00601-2.
2
Clinico-pathological evaluation of restrictive cardiomyopathy (endomyocardial fibrosis and idiopathic restrictive cardiomyopathy) in India.印度限制性心肌病(心内膜心肌纤维化和特发性限制性心肌病)的临床病理评估
Eur J Heart Fail. 2004 Oct;6(6):723-9. doi: 10.1016/j.ejheart.2003.11.009.
3
[Idiopathic restrictive cardiomyopathy: clinical, hemodynamic, histologic and prognostic profile].[特发性限制性心肌病:临床、血流动力学、组织学及预后特征]
Cardiologia. 1989 Sep;34(9):759-68.
4
[Idiopathic restrictive cardiomyopathy].[特发性限制性心肌病]
Arq Bras Cardiol. 1993 Sep;61(3):175-80.
5
Clinical, hemodynamic and endomyocardial biopsy findings in idiopathic restrictive cardiomyopathy.特发性限制性心肌病的临床、血流动力学及心内膜心肌活检结果
West J Med. 1986 Mar;144(3):303-6.
6
Restrictive cardiomyopathy versus constrictive pericarditis: role of endomyocardial biopsy in avoiding unnecessary thoracotomy.限制型心肌病与缩窄性心包炎:心内膜心肌活检在避免不必要开胸手术中的作用
Circulation. 1987 May;75(5):1012-7. doi: 10.1161/01.cir.75.5.1012.
7
[Endomyocardial biopsy in children and adolescents].[儿童及青少年的心内膜心肌活检]
Kardiol Pol. 1989;32(2):87-96.
8
Spectrum of restrictive cardiomyopathy: report of the national survey in Japan.
Am Heart J. 1990 Jul;120(1):188-94. doi: 10.1016/0002-8703(90)90177-y.
9
Controversial issues in restrictive cardiomyopathy.限制型心肌病的争议性问题。
Postgrad Med J. 1992;68 Suppl 1:S47-51.
10
Analysis of left ventricular diastolic function by the pressure-volume relation in cases with idiopathic restrictive cardiomyopathy and amyloid restrictive cardiomyopathy.通过压力-容积关系对特发性限制性心肌病和淀粉样变性限制性心肌病患者左心室舒张功能的分析。
Heart Vessels Suppl. 1990;5:80-3.

引用本文的文献

1
The 'Padua classification' of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic.心肌病的“帕多瓦分类”分为三组:肥厚型/限制型、扩张型/运动减弱型和瘢痕形成/致心律失常型。
Eur Heart J Suppl. 2025 Feb 19;27(Suppl 1):i73-i82. doi: 10.1093/eurheartjsupp/suae108. eCollection 2025 Feb.
2
Identification of novel genetic variants associated with feline cardiomyopathy using targeted next-generation sequencing.使用靶向新一代测序技术鉴定与猫心肌病相关的新型基因变异体。
Sci Rep. 2025 Jan 31;15(1):3871. doi: 10.1038/s41598-025-87852-5.
3
Storytelling of Hypertrophic Cardiomyopathy Discovery.
肥厚型心肌病发现的故事讲述
J Cardiovasc Dev Dis. 2024 Sep 28;11(10):300. doi: 10.3390/jcdd11100300.
4
Genotype-Phenotype Associations with Restrictive Cardiomyopathy Induced by Pathogenic Genetic Mutations.致病性基因突变所致限制性心肌病的基因型-表型关联
Rev Cardiovasc Med. 2022 May 25;23(6):185. doi: 10.31083/j.rcm2306185. eCollection 2022 Jun.
5
Genetically determined cardiomyopathies at autopsy: the pivotal role of the pathologist in establishing the diagnosis and guiding family screening.尸检中的遗传性心肌病:病理学家在确定诊断和指导家族筛查中的关键作用。
Virchows Arch. 2023 Apr;482(4):653-669. doi: 10.1007/s00428-023-03523-8. Epub 2023 Mar 10.
6
Cardiomyocyte Dysfunction in Inherited Cardiomyopathies.遗传性心肌病中心肌细胞功能障碍。
Int J Mol Sci. 2021 Oct 15;22(20):11154. doi: 10.3390/ijms222011154.
7
Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies.肥厚型心肌病与原发性限制型心肌病:异同与表型模拟
J Clin Med. 2021 May 1;10(9):1954. doi: 10.3390/jcm10091954.
8
The Multifaced Perspectives of Genetic Testing in Pediatric Cardiomyopathies and Channelopathies.儿童心肌病和通道病基因检测的多面视角
J Clin Med. 2020 Jul 4;9(7):2111. doi: 10.3390/jcm9072111.
9
Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies.将新兴的分子遗传学见解转化为遗传性心肌病的临床实践。
J Mol Med (Berl). 2018 Oct;96(10):993-1024. doi: 10.1007/s00109-018-1685-y. Epub 2018 Aug 20.
10
CSI position statement on management of heart failure in India.印度心脏病学会关于心力衰竭管理的立场声明。
Indian Heart J. 2018 Jul;70 Suppl 1(Suppl 1):S1-S72. doi: 10.1016/j.ihj.2018.05.003. Epub 2018 Jun 8.